WordNet

a salt or ester of maleic acid; used as a nontricyclic antidepressant drug for psychomotor activation

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 安定期慢性閉塞性肺疾患：初期薬物療法stable copd initial pharmacologic management [show details]
…mcg twice daily . Indacaterol – Indacaterol is a once-daily LABA that is approved for the treatment of COPD . It has a rapid onset and a long duration of action. The dose of indacaterol approved for use …
2. 喘息におけるβ刺激剤：長期使用に関する議論beta agonists in asthma controversy regarding chronic use [show details]
…with ICS alone, as described below. Once daily LABAs (24 hour duration of action), such as indacaterol, olodaterol, and vilanterol , have been approved by the US Food and Drug Administration (FDA) for…
3. 安定期慢性閉塞性肺疾患: フォローアップ薬物療法stable copd follow up pharmacologic management [show details]
…long-term triple therapy but infrequent exacerbations were randomly assigned to glycopyrronium-indacaterol or tiotropium-salmeterol-fluticasone in two inhalers . In the group without ICS, a small decrease …
4. COPDの増悪：マネージメントcopd exacerbations management [show details]
…rapid-onset, long-acting beta agonist, like indacaterol, would be a reasonable substitute for albuterol nebulizer treatments in patients not already using indacaterol . We suggest use of the combination of…
5. 成人における吸入器の使用the use of inhaler devices in adults [show details]
…part of the canister. The RespiClick resembles the pMDI in appearance. Single-dose devices (eg, indacaterol [Arcapta Neohaler], tiotropium [Spiriva Handihaler], insulin [Afrezza], levodopa (Inbrija), tobramycin…

English Journal

Spectrophotometric and spectrofluorimetric determination of indacaterol maleate in pure form and pharmaceutical preparations: application to content uniformity.

El-Ashry SM1, El-Wasseef DR1, El-Sherbiny DT1,2, Salem YA2.
Luminescence : the journal of biological and chemical luminescence.Luminescence.2015 Sep;30(6):891-7. doi: 10.1002/bio.2838. Epub 2015 Jan 26.
Two simple, rapid, sensitive and precise spectrophotometric and spectrofluorimetric methods were developed for the determination of indacaterol maleate in bulk powder and capsules. Both methods were based on the direct measurement of the drug in methanol. In the spectrophotometric method (Method I)
PMID 25620654

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.

Beasley RW1, Donohue JF2, Mehta R3, Nelson HS4, Clay M5, Moton A6, Kim HJ6, Hederer BM7.
BMJ open.BMJ Open.2015 Feb 3;5(2):e006131. doi: 10.1136/bmjopen-2014-006131.
OBJECTIVE: To investigate the safety and efficacy of QMF149, a once-daily, fixed-dose combination of the long-acting β2-agonist (LABA) indacaterol maleate and inhaled corticosteroid (ICS) mometasone furoate (MF) for the treatment of persistent asthma. The hypothesis was that QMF149 would not increa
PMID 25649209

Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.

Prakash A1, Babu KS2, Morjaria JB3.
International journal of chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis.2015 Jan 7;10:111-23. doi: 10.2147/COPD.S67758. eCollection 2015.
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality. The cornerstone of pharmacological treatment for COPD is bronchodilation. Inhaled glycopyrronium bromide is a long-acting muscarinic antagonist developed as a maintenance treatment for patients with COPD. Phase
PMID 25609944